logo
California study finds ER visits spiking with heat, but overall deaths falling from lack of cold

California study finds ER visits spiking with heat, but overall deaths falling from lack of cold

The Hill6 days ago
Californians are poised to become sicker in a future marked by climate-fueled warming, but they may also be less likely to die from temperature-related events as extreme cold days become rarer, a new study has found.
Emergency room visits in California increased in a linear fashion as daily temperatures escalated over the course of a recent decade, from 2006 to 2017, according to the study, published on Wednesday in Science Advances. But neither hospital admissions or related-death exhibited the same unbending climb.
Although extreme heat and extreme cold alike cause more people to die, illness rates tend to increase as the weather becomes hotter, and they tend to be lower in colder conditions, the study authors explained.
In other words: Emergency visits are still likely to surge as the planet warms, but temperature-related deaths as a whole may decline thanks to the ongoing disappearance of extreme cold days.
The researchers — led by Carlos Gould at the University of California San Diego — analyzed 123 million zip code-level emergency department visits, 45 million such hospital admissions and 2.9 million county-level death records between 2006 and 2017. They also compiled daily temperature records from 1,500 zip codes in 56 California counties for the same period.
Over time, they observed that the zip codes experienced an increase in emergency room visits: from an average of 1,936 per 100,000 people every month to 2,531 in 2017.
During the same window, both hospitalization rates and deaths showed a U-curve for temperature — exhibiting unsurprising increases during extreme cold and hot periods.
The scientists calculated an increase in emergency department visits California due to changes in temperatures by 2050 — an additional 0.46 percent, or 1.5 million excess visits, in comparison to today.
At that point, related hospitalizations and deaths will both likely decline, by 0.18 percent and 0.43 percent, respectively, or 244,000 fewer hospitalizations and 53,500 fewer deaths, according to the study.
By 2100, the researchers projected a 0.76 percent increase in emergency department visits, a 0.38 percent decline in hospital admissions and a 0.77 plunge in deaths due to temperature changes.
As far as economics are concerned, the scientists calculated that by 2050, emergency room visits would cost California an additional $52 million, while temperature-related death costs would decrease by $30 billion and hospitalization costs by $53 million.
Going forward, the researchers called for further analysis into the morbidity and mortality — illness and death — impacts of temperature variation within populations, noting that specific effects may differ considerably among age groups.
'A very broad range of morbidity outcomes will likely be affected by a warming climate and that future increases in heat extremes will increase both morbidity and mortality,' the authors stated.
And with a much warmer future likely ahead, the researchers questioned just how long the decreases in death related to cold could truly outweigh the increases related to excessive warmth.
'Our results suggest that beneficial impact of declining cold extremes for mortality — an expected substantial benefit of climate change in much of the world — will be offset, at least partially, by increases in morbidity at those temperatures,' they added.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cognitive Impact From Dementia Risk Factors Greater in Women
Cognitive Impact From Dementia Risk Factors Greater in Women

Medscape

time15 hours ago

  • Medscape

Cognitive Impact From Dementia Risk Factors Greater in Women

TORONTO — A number of modifiable risk factors are more common in women than in men and have a greater impact on cognition, an early look at new research showed. Six modifiable dementia risk factors were more prevalent in women, whereas only three were more common in men. Investigators also found that the impact on cognition from some of these factors was greater in women than in men, especially hearing loss and diabetes. However, the impact of these and other risk factors varied by age. Megan Fitzhugh, PhD The results suggest personalized health and lifestyle interventions should consider both sex and age, study author Megan Fitzhugh, PhD, assistant professor, Department of Neurosciences, University of California San Diego, told Medscape Medical News. 'Clinicians should familiarize themselves with the 14 identified modifiable risk factors, and if their patients have these risk factors, consider their sex and age, and try to target the behavior changes accordingly to minimize the impact on cognition and dementia risk,' Fitzhugh said. The findings were presented on July 28 at the Alzheimer's Association International Conference (AAIC) 2025. At Greater Risk It's well-known that women are at greater risk for dementia. The lifetime risk for Alzheimer's disease (AD) is 1 in 5 for women compared with 1 in 10 for men. Sex-specific factors such as pregnancy and menopause may contribute to this imbalance. But while many researchers tackle this issue from a biological perspective, Fitzhugh focuses on the effects of modifiable risk factors. She used the 2008 wave of the Health and Retirement study, an ongoing population-based study of a representative sample of American retirees and their spouses who complete questionnaire every 2 years (in 'waves'). After excluding anyone younger than 40 years and those without self-reported risk factor information, the study sample included 17,182 individuals. Fitzhugh concentrated on items included in the Lancet Report on Dementia Prevention. As reported by Medscape Medical News , 45% of dementia risk factors are potentially modifiable. Risk factors identified in the Lancet report include less education in early life (contributing 5% to risk); hearing loss (7%), elevated low density lipoprotein (LDL) cholesterol (7%), depression (3%), traumatic brain injury (3%), physical inactivity (2%), diabetes (2%), smoking (2%), hypertension (2%), obesity (1%), and excessive alcohol (1%) in midlife; and social isolation (5%), air pollution (3%), and vision loss (2%) in late life. Looking at prevalence, investigators found that six of the 14 risk factors were more common in women, including physical inactivity, depression, smoking, poor sleep, less education and poor vision (for example, glaucoma or cataracts). Only three risk factors were more common in men, including hearing loss, diabetes, and alcohol use. There was no difference in prevalence between men and women in high BMI, hypertension, and social isolation. Plotting Cognition The Health and Retirement Study also gathers data on global cognition (immediate recall, delayed recall, numeracy, etc.) using a 27-item scale. Fitzhugh separated mean cognitive scores for men and women and for three age groups (middle age: 40-59 years; middle to older age: 60-79 years; and oldest age: 80 years and over), then plotted risk factors in each group. The graphs she created illustrate the differences in cognitive performance between having and not having a risk factor for each sex. For example, the diabetes plot shows this risk factor has a much bigger impact on cognition in women. 'The line for men is relatively flat, so their cognition is really the same if they have diabetes or not, but for women, if they have diabetes, cognition is much lower compared to women who don't have diabetes', explained Fitzhugh. In addition to diabetes, other risk factors that have a greater cognitive impact on women included poor sleep, BMI, hypertension, poor vision, less education, and hearing loss. Along with high LDL, hearing loss is the largest modifiable risk factor, accounting for 7% of dementia risk, according to the Lancet Commission report. But even though more men have hearing loss across all ages, it appears to be more impactful on women in terms of cognition, said Fitzhugh. 'Maybe we should be targeting women with hearing loss in middle to older age, making sure they get hearing aids,' she said. Elsewhere in her research, Fitzhugh found women with hearing loss have a greater risk for dementia than men with hearing loss. 'There's something about hearing loss in women that is particularly detrimental.' The cognitive impact of risk factors also varies by age, investigators found. Among women, the impact of hearing loss was greatest in middle to older age. Poor sleep only had a significant impact in middle age, which coincides with the menopause transition. And in the oldest age, less education was the only risk factor to have a significant impact on cognition. In men, only smoking had a greater cognitive impact, but interestingly, only in the older age group. 'The way I think about age in this study is it's telling us when, potentially, we should be targeting these risk factors,' said Fitzhugh. She recognizes this is 'just a snapshot' in time and said she'd like to 'map out' how risk factors impact cognition over time. Commenting on the research, Liisa Galea, PhD, Treliving Family Chair in Women's Mental Health, Centre for Addiction and Mental Health, and professor of psychiatry, University of Toronto, Toronto, Ontario, Canada, said that more modifiable factors are associated with cognition in females than males is 'most surprising.' 'Clearly these factors are important for everyone, but we need more targeted messaging to women across the lifespan about the importance of these variables for their brain health,' Galea said.

American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity

Business Wire

timea day ago

  • Business Wire

American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity

SAN FRANCISCO--(BUSINESS WIRE)--The American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision oncology company focused on improving access to cancer screening and advancing health equity. This collaboration supports ACS's nationwide cancer screening efforts, including the I Love You, Get Screened public awareness campaign; community-based health system partnerships; and state coalition work aimed at removing barriers to lifesaving screenings. ACS and Guardant Health aim to increase awareness, promote early detection, and improve outcomes for individuals in communities that have historically experienced limited access to preventive care. 'Regular cancer screening saves lives by finding certain cancers early, when they are often easier to treat or even prevent altogether,' said Maria Olson, Executive Vice President, American Cancer Society. 'With support from Guardant Health, we can reach more people across the Bay Area with the information, tools, and services they need to take action for their health.' Despite being a hub of healthcare innovation, California continues to fall behind the national average in key cancer screening rates. Data from the American Cancer Society shows that only 64% of California women aged 45 and older are up to date on screening mammograms, compared to 69% nationally. Colorectal cancer screening rates are also lower, with 60% of eligible Californians screened compared to 62% nationwide. These gaps represent a critical opportunity to expand access and close the screening disparity. In 2025, an estimated 2,041,910 people in the U.S. will be diagnosed with cancer, and more than 600,000 lives are expected to be lost due to cancer. However, due to reductions in smoking and advances in early detection and treatment, cancer mortality has dropped 34% from 1991 to 2022, averting approximately 4.5 million deaths during that time. This work aims to accelerate that momentum, with a special focus on communities that remain underserved. Guardant Health will support the following ACS initiatives: Expanding the reach of the I Love You, Get Screened campaign, which garnered over 313 million impressions in 2024 and delivers culturally relevant education to communities including Black/African American, Hispanic/Latino, and LGBTQ+ populations. Promoting digital tools on including a locator tool that helps individuals find more than 15,000 screening locations across the U.S. Supporting community health interventions, such as patient education, navigation to screening appointments, transportation support, and language access services. These efforts contributed to over 555,000 completed screenings and 7,800 cancers detected in 2024. Collaborating with state coalitions, including those in California, to implement localized strategies that help increase screening rates and reduce disparities. 'Guardant Health is proud to partner with the American Cancer Society in the fight to expand cancer screening access,' said AmirAli Talasaz, Guardant Health co-founder and co-CEO. 'We share a commitment to ensuring that everyone, regardless of race, ethnicity, income, or ZIP code, has access to convenient and timely cancer screening, so we can detect cancer earlier and give them the opportunity for a better outcome.' Throughout 2025, ACS will engage communities across the nation through impactful campaigns aligned with key cancer awareness months—including cervical cancer awareness in January, colorectal in March, prostate in September, breast in October, and lung in November. These efforts will feature personal stories, local events, and trusted education to empower more people to get screened and take charge of their health. To learn more about ACS screening tools or to find a local screening center, visit About the American Cancer Society The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, X, and Instagram. About Guardant Health Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit and follow the company on LinkedIn, X (Twitter) and Facebook.

Wearable devices helped spot postsurgical complications in kids
Wearable devices helped spot postsurgical complications in kids

Washington Post

time2 days ago

  • Washington Post

Wearable devices helped spot postsurgical complications in kids

Wearable devices like Fitbits can help health care providers spot postsurgical complications in kids, a new analysis in Science Advances finds. About 1 in 7 children will have postoperative complications, but diagnoses can be delayed because they can be difficult for caretakers outside the hospital to spot. To determine if data recorded by wearable devices can help predict recovery in children, researchers gave Fitbits to 103 children ages 3 to 18. All were recovering from an appendectomy, a common surgery in kids. The devices monitored heart rate and step-count data, sleep and other biometrics. They recorded 2,163 total monitoring days. The researchers used the data to find circadian patterns in the children's biometrics during each day after their surgery. Of 94 children whose data could be used, 58 had a normal recovery, 23 had abnormal symptoms such as diarrhea but no ultimate complication, and 13 had a postoperative complication. The researchers used a machine-learned model to predict complications using the Fibits and biorhythms. Daily patterns associated with activity, such as step count, ended up being the most important to predicting post-appendectomy recovery, followed by heart rhythms. Tracking biorhythms for as little as 120 minutes produced robust enough data for the model to analyze. Overall, the researchers were able to predict postoperative complications using the wearable data with 91 percent sensitivity and 74 percent specificity. 'In our data, 89% of patients who had complications after discharge were readmitted and were all correctly predicted by the biorhythm model,' they write. Other research suggests biorhythms may not be as effective at tracking adults' postoperative recovery. It might be easier to use biometrics to predict children's recoveries because their lives are more structured, making it easier to establish a typical baseline for analysis, the researchers add. Other studies should focus on other childhood procedures including tonsillectomies, the researchers suggest. But overall, the researchers write, the study shows that consumer wearables and monitoring could help 'address key challenges in postoperative monitoring of children.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store